MORGAN STANLEY - 31 Aug 2025 SCHEDULE 13G Report for EVOKE PHARMA INC Common Stock (EVOK)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: EVOKE PHARMA INC Common Stock
Symbol: EVOK
Shares outstanding: 1,559,219 shares
Disclosed Ownership: 163,718 shares
Ownership: 10%
Form type: SCHEDULE 13G
Filing time: 08 Sep 2025, 16:33:20 UTC
Date of event: 31 Aug 2025
Next filing: 05 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	10%	163,718	0	0	Christopher O'Hara	Authorized Signatory, Morgan Stanley
Morgan Stanley Smith Barney LLC	10%	163,718	0	0	David Galasso	Authorized Signatory, Morgan Stanley Smith Barney LLC